{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:00:45Z","timestamp":1793448045336,"version":"4.5.0"},"reference-count":151,"publisher":"Centers for Disease Control MMWR Office","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr6701a1","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T11:14:55Z","timestamp":1515669295000},"page":"1-31","source":"Crossref","is-referenced-by-count":631,"title":["Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices"],"prefix":"10.15585","volume":"67","author":[{"given":"Sarah","family":"Schillie","sequence":"first","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vellozzi","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Reingold","sequence":"additional","affiliation":[{"name":"University of California, Berkeley School of Public Health, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penina","family":"Haber","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Ward","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noele P.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R1","first-page":"1","article-title":"Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis.","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R2","first-page":"2012","article-title":"PHS guidelines for management of occupational exposure to HBV, HCV and HIV: management of occupational blood exposures.","volume":"64","author":"Preboth","year":"2001","journal-title":"Am Fam Physician"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(81)92877-4","article-title":"Survival of hepatitis B virus after drying and storage for one week.","volume":"317","author":"Bond","year":"1981","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R4","unstructured":"CDC. Viral hepatitis\u2014statistics and surveillance. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.cdc.gov\/hepatitis\/statistics\/"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B.","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R6","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R7","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: immunization of infants, children, and adolescents.","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R8","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R9","first-page":"1709","article-title":"Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R10","first-page":"1","article-title":"CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.","volume":"62","author":"Schillie","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R11","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.15585\/mmwr.mm6439a6","article-title":"Update: shortened interval for postvaccination serologic testing of infants born to hepatitis b-infected mothers.","volume":"64","author":"Schillie","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R12","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R13","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001.","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R14","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R15","unstructured":"CDC. Surveillance data for acute viral hepatitis\u2014United States, 2008. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2008surveillance\/index.htm"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","article-title":"Increases in acute hepatitis B virus infections\u2014Kentucky, Tennessee, and West Virginia, 2006\u20132013.","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/hep.28109","article-title":"Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012.","volume":"63","author":"Roberts","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1086\/653622","article-title":"The prevalence of hepatitis B virus infection in the United States in the era of vaccination.","volume":"202","author":"Wasley","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.24804","article-title":"Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin.","volume":"56","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R20","doi-asserted-by":"publisher","first-page":"e27717","DOI":"10.1371\/journal.pone.0027717","article-title":"The increasing burden of imported chronic hepatitis B\u2014United States, 1974\u20132008.","volume":"6","author":"Mitchell","year":"2011","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R21","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).","volume":"40","author":"CDC","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R22","first-page":"317","article-title":"Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine.","volume":"31","author":"CDC","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R23","first-page":"429","article-title":"Changing patterns of groups at high risk for hepatitis B in the United States.","volume":"37","author":"CDC","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R24","first-page":"377","article-title":"Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.","volume":"37","author":"CDC","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R25","first-page":"341","article-title":"Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen.","volume":"37","author":"CDC","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R26","first-page":"33","article-title":"Update: recommendations to prevent hepatitis B virus transmission\u2014United States.","volume":"48","author":"CDC","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R27","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1097\/INF.0000000000001516","article-title":"Hepatitis B surface antigen testing among pregnant women, United States 2014.","volume":"36","author":"Kolasa","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R28","doi-asserted-by":"publisher","first-page":"828","DOI":"10.7326\/M13-2529","article-title":"Prevention of vertical transmission of hepatitis B: an observational study.","volume":"160","author":"Kubo","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R29","doi-asserted-by":"publisher","first-page":"e1141","DOI":"10.1542\/peds.2014-3213","article-title":"Outcomes of infants born to women infected with hepatitis B.","volume":"135","author":"Schillie","year":"2015","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.15585\/mmwr.mm6643a3","article-title":"Vaccination coverage among children aged 19\u201335 months\u2014United States, 2016.","volume":"66","author":"Hill","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R31","first-page":"825","article-title":"Newborn hepatitis B vaccination coverage among children born January 2003-June 2005\u2014United States.","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R32","unstructured":"US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2014. https:\/\/www.healthypeople.gov\/"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R33","doi-asserted-by":"publisher","first-page":"874","DOI":"10.15585\/mmwr.mm6633a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2016.","volume":"66","author":"Walker","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015.","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2307\/30143095","article-title":"Impact of the bloodborne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine.","volume":"16","author":"Agerton","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/AOG.0000000000000124","article-title":"Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load.","volume":"123","author":"Fan","year":"2014","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R37","unstructured":"CDC; The American College of Obstetricians and Gynecologists. Screening pregnant women for hepatitis B virus (HBV) infection. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https:\/\/www.cdc.gov\/hepatitis\/hbv\/pdfs\/prenatalhbsagtesting.pdf"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.cgh.2011.10.041","article-title":"An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus.","volume":"10","author":"Pan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cgh.2012.01.019","article-title":"Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.","volume":"10","author":"Pan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/sj.icb.7100009","article-title":"Immunopathogenesis of hepatitis B virus infection.","volume":"85","author":"Chang","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.antiviral.2015.06.008","article-title":"Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.","volume":"121","author":"Gish","year":"2015","journal-title":"Antiviral Res"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1055\/s-2008-1040426","article-title":"Serologic diagnosis of acute and chronic viral hepatitis.","volume":"11","author":"Hoofnagle","year":"1991","journal-title":"Semin Liver Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1056\/NEJM197901183000301","article-title":"Viral hepatitis, type B. Studies on natural history and prevention re-examined.","volume":"300","author":"Krugman","year":"1979","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R44","unstructured":"Long SS, Prober CG, Fischer M. Principles and practice of pediatric infectious diseases. 5th ed. Amsterdam, the Netherlands: Elsevier; 2017."},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000150411","article-title":"Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene.","volume":"38","author":"Magnius","year":"1995","journal-title":"Intervirology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus.","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/rmv.1885","article-title":"The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics.","volume":"26","author":"Kramvis","year":"2016","journal-title":"Rev Med Virol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tracli.2003.11.007","article-title":"Occult hepatitis B virus infection.","volume":"11","author":"Allain","year":"2004","journal-title":"Transfus Clin Biol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R49","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection.","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.","volume":"151","author":"McMahon","year":"1985","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/BF01951493","article-title":"Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection.","volume":"3","author":"Dienstag","year":"1981","journal-title":"Springer Semin Immunopathol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R52","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.","volume":"322","author":"Beasley","year":"1983","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state.","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc Biol Sci"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R54","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","article-title":"Risks of chronicity following acute hepatitis B virus infection: a review.","volume":"20","author":"Hyams","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R55","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/infdis\/163.3.454","article-title":"Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.","volume":"163","author":"Hadler","year":"1991","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R56","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.","volume":"318","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R57","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact.","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R58","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/archinte.1990.00390170087019","article-title":"Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.","volume":"150","author":"McMahon","year":"1990","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.28278","article-title":"Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis.","volume":"63","author":"Jonas","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R60","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mcna.2013.08.004","article-title":"Chronic hepatitis B virus infection.","volume":"98","author":"McMahon","year":"2014","journal-title":"Med Clin North Am"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R62","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cgh.2016.06.023","article-title":"Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents.","volume":"15","author":"Wang","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R63","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1093\/jpids\/piu064","article-title":"Prevention of perinatal hepatitis B virus transmission.","volume":"3","author":"Nelson","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R64","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.vaccine.2012.12.012","article-title":"Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review.","volume":"31","author":"Schillie","year":"2013","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R65","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10096-012-1781-9","article-title":"Atypical serological profiles in hepatitis B virus infection.","volume":"32","author":"Pond\u00e9","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R66","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00705-009-0559-6","article-title":"The underlying mechanisms for the \u2018anti-HBc alone\u2019 serological profile.","volume":"155","author":"Pond\u00e9","year":"2010","journal-title":"Arch Virol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R67","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM198911093211905","article-title":"Hepatitis B virus infection among children born in the United States to Southeast Asian refugees.","volume":"321","author":"Franks","year":"1989","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.diagmicrobio.2015.12.005","article-title":"Are current screening protocols for chronic hepatitis B virus infection adequate?","volume":"85","author":"Mortensen","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R69","doi-asserted-by":"publisher","first-page":"bcr2013202191","DOI":"10.1136\/bcr-2013-202191","article-title":"Persistence of hepatitis B surface antigen in blood in a chronic haemodialysis patient following vaccination booster.","volume":"2014","author":"Calisti","year":"2014","journal-title":"BMJ Case Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R70","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y","article-title":"Serological pattern \u201canti-HBc alone\u201d: report on a workshop.","volume":"62","author":"Grob","year":"2000","journal-title":"J Med Virol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R71","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1086\/513918","article-title":"Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.","volume":"26","author":"Silva","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R72","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/gutjnl-2011-301281","article-title":"Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.","volume":"61","author":"Candotti","year":"2012","journal-title":"Gut"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R73","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.transproceed.2004.12.041","article-title":"Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.","volume":"37","author":"De Feo","year":"2005","journal-title":"Transplant Proc"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R74","unstructured":"Council of State and Territorial Epidemiologists. Hepatitis B, perinatal virus infection 2017 case definition. Atlanta, GA: Council of State and Territorial Epidemiologists; 2017. https:\/\/wwwn.cdc.gov\/nndss\/conditions\/hepatitis-b-perinatal-virus-infection\/case-definition\/2017\/"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R75","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R76","unstructured":"CDC. Viral hepatitis\u2014CDC recommendations for specific populations and settings. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https:\/\/www.cdc.gov\/hepatitis\/populations\/stds.htm"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1542\/peds.89.2.269","article-title":"Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees.","volume":"89","author":"Hurie","year":"1992","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/oxfordjournals.aje.a112363","article-title":"Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.","volume":"105","author":"Chaudhary","year":"1977","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-150-1-200901060-00007","article-title":"Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008.","volume":"150","author":"Thompson","year":"2009","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R80","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1016\/j.vaccine.2012.02.078","article-title":"Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak.","volume":"30","author":"Williams","year":"2012","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R81","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1352\/0895-8017(2002)107<0278:POHVII>2.0.CO;2","article-title":"Prevalence of hepatitis virus infections in an institution for persons with developmental disabilities.","volume":"107","author":"Woodruff","year":"2002","journal-title":"Am J Ment Retard"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2105\/AJPH.91.1.31","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.","volume":"91","author":"Rosenberg","year":"2001","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R83","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R84","first-page":"1","article-title":"Prevention and control of infections with hepatitis viruses in correctional settings.","volume":"52","author":"Weinbaum","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/oxfordjournals.aje.a113277","article-title":"Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?","volume":"115","author":"Dienstag","year":"1982","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1017\/S0195941700062457","article-title":"Occupational risk of hepatitis B infection in hospital workers.","volume":"6","author":"Hadler","year":"1985","journal-title":"Infect Control"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R87","unstructured":"US Department of Labor. Occupational Safety and Health Administration. OSHA Law and Regulations. https:\/\/www.osha.gov\/law-regs.html"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R88","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients.","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R89","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/infdis\/153.6.1149","article-title":"Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States.","volume":"153","author":"Alter","year":"1986","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R90","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1525-139X.2005.18108.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002.","volume":"18","author":"Finelli","year":"2005","journal-title":"Semin Dial"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R91","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years\u2014Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012.","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R92","first-page":"359","article-title":"Hepatitis A and hepatitis B vaccination of patients with chronic liver disease.","volume":"63","author":"Bell","year":"2000","journal-title":"Acta Gastroenterol Belg"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jtm.12026","article-title":"Hepatitis B and C infection in international travelers.","volume":"20","author":"Johnson","year":"2013","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R94","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects.","volume":"188","author":"Kellerman","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R95","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1086\/649885","article-title":"Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.","volume":"50","author":"Chun","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R96","first-page":"416","article-title":"High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection.","volume":"4","author":"Homann","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R97","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-2003-39951","article-title":"Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.","volume":"23","author":"Thio","year":"2003","journal-title":"Semin Liver Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R98","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection.","volume":"44","author":"Alter","year":"2006","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R99","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R100","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1177\/193229681200600417","article-title":"Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus.","volume":"6","author":"Reilly","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R101","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2893.2012.01616.x","article-title":"Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999\u20132010.","volume":"19","author":"Schillie","year":"2012","journal-title":"J Viral Hepat"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R102","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1056\/NEJM199203123261101","article-title":"Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device.","volume":"326","author":"Polish","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R103","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0163-4453(86)92563-6","article-title":"Production and immunological analysis of recombinant hepatitis B vaccine.","volume":"13","author":"Emini","year":"1986","journal-title":"J Infect"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R104","doi-asserted-by":"crossref","unstructured":"Stephenne J. Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine 1990;8(Suppl):S69\u201373, discussion S79\u201380.","DOI":"10.1016\/0264-410X(90)90221-7"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R105","unstructured":"CDC. Update: expanded availability of thimerosal preservative-free hepatitis B vaccine. MMWR Morb Mortal Wkly Rep 2000;49:642\u201351"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R106","unstructured":"US Food and Drug Administration. Licensed biological products with supporting documents. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2017. https:\/\/www.fda.gov\/biologicsbloodvaccines\/ucm133705.htm"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R107","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1086\/314578","article-title":"What level of hepatitis B antibody is protective?","volume":"179","author":"Jack","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R108","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose.","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R109","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose.","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R110","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/infdis\/jiw142","article-title":"A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen.","volume":"214","author":"Simons","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R111","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/0002-9343(89)90525-1","article-title":"Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.","volume":"87","author":"Andr\u00e9","year":"1989","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R112","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.2337\/dc12-0312","article-title":"Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature.","volume":"35","author":"Schillie","year":"2012","journal-title":"Diabetes Care"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","article-title":"Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.","volume":"15","author":"Averhoff","year":"1998","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R114","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0264-410X(89)90157-6","article-title":"Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination.","volume":"7","author":"Shaw","year":"1989","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R115","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1186\/1471-2458-14-820","article-title":"Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.","volume":"14","author":"Bowman","year":"2014","journal-title":"BMC Public Health"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R116","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/oxfordjournals.ndt.a091892","article-title":"Vaccination against hepatitis B in children and adolescent patients on dialysis.","volume":"4","author":"Drachman","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R117","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/bmj.38719.435833.7C","article-title":"Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.","volume":"332","author":"Lee","year":"2006","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R118","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0022-3476(97)70078-7","article-title":"Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants.","volume":"131","author":"Patel","year":"1997","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R119","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0264-410X(97)00233-8","article-title":"A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults.","volume":"16","author":"Marsano","year":"1998","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R120","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1542\/peds.107.4.626","article-title":"A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.","volume":"107","author":"Cassidy","year":"2001","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R121","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.vaccine.2012.01.064","article-title":"Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.","volume":"30","author":"Fabrizi","year":"2012","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R122","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/00006454-199511000-00002","article-title":"Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy.","volume":"14","author":"Hovi","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R123","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0264-410X(92)90050-T","article-title":"Impaired response to hepatitis B vaccine in HIV infected children.","volume":"10","author":"Zuin","year":"1992","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R124","unstructured":"World Health Organization. Information sheet observed rate of vaccine reactions: hepatitis B vaccine. Geneva, Switzerland: World Health Organization; 2012. http:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/Hep_B_Vaccine_rates_information_sheet.pdf"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R125","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents.","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R126","unstructured":"Stratton K, Ford A, Rusch E, Clayton EW, eds. Adverse effects of vaccines: evidence and causality. Washington, DC: National Academy Press; 2012."},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R127","unstructured":"Stratton K, Almario D, McCormick MC, editors. Immunization safety review: hepatitis B vaccine and demyelinating neurological disorders. Washington, DC: National Academies Press; 2002."},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R128","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00006454-199901000-00007","article-title":"Hepatitis B vaccine and central nervous system demyelinating diseases.","volume":"18","author":"Halsey","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R129","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/pds.1408","article-title":"Hepatitis B vaccine and risk of multiple sclerosis.","volume":"16","author":"DeStefano","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R130","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1016\/j.vaccine.2011.06.112","article-title":"Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15\u201359 years of age.","volume":"29","author":"Ray","year":"2011","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R131","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/aje\/kws011","article-title":"Immunization and Bell\u2019s palsy in children: a case-centered analysis.","volume":"175","author":"Rowhani-Rahbar","year":"2012","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R132","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/pds.1354","article-title":"Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.","volume":"16","author":"Yu","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R133","doi-asserted-by":"publisher","first-page":"7394","DOI":"10.1016\/j.vaccine.2009.09.023","article-title":"Risk of immune hemolytic anemia in children following immunization.","volume":"27","author":"Naleway","year":"2009","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R134","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults.","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R135","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/cid\/ciw224","article-title":"Case-centered analysis of optic neuritis after vaccines.","volume":"63","author":"Baxter","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R136","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain-Barr\u00e9 syndrome with vaccinations.","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R137","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/0194599816639043","article-title":"Sudden-onset sensorineural hearing loss after immunization: a case-centered analysis.","volume":"155","author":"Baxter","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R138","article-title":"Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine adverse event reporting system (VAERS), 2005\u20132015","author":"Haber","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R139","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0264-410X(89)90046-7","article-title":"Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians.","volume":"7","author":"Hadler","year":"1989","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R140","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1542\/peds.103.6.1243","article-title":"Hepatitis B vaccine administered to children and adolescents at yearly intervals.","volume":"103","author":"Halsey","year":"1999","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R141","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0264-410X(99)00012-2","article-title":"Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose.","volume":"17","author":"Wistr\u00f6m","year":"1999","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R142","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/infdis\/160.5.766","article-title":"Vaccination against hepatitis B: comparison of three different vaccination schedules.","volume":"160","author":"Jilg","year":"1989","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R143","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jama.1994.03510350069039","article-title":"Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization.","volume":"271","author":"Tan","year":"1994","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R144","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hep.28302","article-title":"Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.","volume":"63","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R145","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12879-016-1734-5","article-title":"Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.","volume":"16","author":"Jourdain","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R146","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/jvh.12379","article-title":"Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection.","volume":"22","author":"Han","year":"2015","journal-title":"J Viral Hepat"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R147","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/hep.28310","article-title":"Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.","volume":"63","author":"Fan","year":"2016","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R148","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1542\/peds.2013-0718","article-title":"Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.","volume":"133","author":"Barbosa","year":"2014","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R149","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2337\/dc12-0759","article-title":"Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes.","volume":"36","author":"Hoerger","year":"2013","journal-title":"Diabetes Care"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R150","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1086\/676865","article-title":"Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.","volume":"35","author":"Hoerger","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.rr6701a1-201801111114-R151","first-page":"1","article-title":"General recommendations on immunization\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"60","year":"2011","journal-title":"MMWR Recomm Rep"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T02:57:24Z","timestamp":1660273044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/67\/rr\/rr6701a1.htm?s_cid=rr6701a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":151,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,12]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr6701a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,12]]},"published":{"date-parts":[[2018,1,12]]}}}